Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction (Q24202513)

From Wikidata
Jump to navigation Jump to search
scientific article (publication date: 8 November 2013)
edit
Language Label Description Also known as
English
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction
scientific article (publication date: 8 November 2013)

    Statements

    Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction (English)
    0 references
    0 references
    Taghride Dahhan
    0 references
    Eva Balkenende
    0 references
    Sabine Linn
    0 references
    8 November 2013
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit